One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
New Guidelines and a focus on ischaemic heart disease, atrial fibrillation, innovative treatments of channelopathies
doi : 10.1093/eurheartj/ehae638
Volume 45, Issue 36, 21 September 2024
From a club of friends to an institution: past successes and future challenges for the European Society of Cardiology
Heart and soul: Jean-François Riffaud on his first year at the helm of the European Society of Cardiology
Weekly Journal Scan: The prognostic value of coronary inflammation in patients with non-obstructive coronary artery disease
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): Developed by the task force for the management of atrial fibrillation of the European Society of Cardiology (ESC), with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO)
2024 ESC Guidelines for the management of chronic coronary syndromes: Developed by the task force for the management of chronic coronary syndromes of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS)
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases: Developed by the task force on the management of peripheral arterial and aortic diseases of the European Society of Cardiology (ESC) Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS), the European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN), and the European Society of Vascular Medicine (ESVM)
Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelines
Gender and contemporary risk of adverse events in atrial fibrillation
CHA2DS2-VASc or a non-sex score (CHA2DS2-VA) for stroke risk prediction in atrial fibrillation: contemporary insights and clinical implications
Long-term outcomes of high bleeding risk patients undergoing percutaneous coronary intervention: a Korean nationwide registry
Bleeding risk should guide antithrombotic treatment after percutaneous coronary intervention: a Copernican revolution
Atherosclerosis quantification and cardiovascular risk: the ISCHEMIA trial
Vulnerable plaque and major adverse cardiovascular events: anatomy of a failure
KCNQ1 suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndrome
Six-vessel fenestrated physician-modi�ed stent grafts for treating thoracic aortic dissecting aneurysm and giant abdominal aortic aneurysm
Correction to: Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial
Correction to: An autoantibody profile detects Brugada syndrome and identifies abnormally expressed myocardial proteins
